Journal of Biological Chemistry 2015-01-09

p53 protein-mediated up-regulation of MAP kinase phosphatase 3 (MKP-3) contributes to the establishment of the cellular senescent phenotype through dephosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2).

Hui Zhang, Yuan Chi, Kun Gao, Xiling Zhang, Jian Yao

文献索引:J. Biol. Chem. 290(2) , 1129-40, (2015)

全文:HTML全文

摘要

Growth arrest is one of the essential features of cellular senescence. At present, the precise mechanisms responsible for the establishment of the senescence-associated arrested phenotype are still incompletely understood. Given that ERK1/2 is one of the major kinases controlling cell growth and proliferation, we examined the possible implication of ERK1/2. Exposure of normal rat epithelial cells to etoposide caused cellular senescence, as manifested by enlarged cell size, a flattened cell body, reduced cell proliferation, enhanced β-galactosidase activity, and elevated p53 and p21. Senescent cells displayed a blunted response to growth factor-induced cell proliferation, which was preceded by impaired ERK1/2 activation. Further analysis revealed that senescent cells expressed a significantly higher level of mitogen-activated protein phosphatase 3 (MKP-3, a cytosolic ERK1/2-targeted phosphatase), which was suppressed by blocking the transcriptional activity of the tumor suppressor p53 with pifithrin-α. Inhibition of MKP-3 activity with a specific inhibitor or siRNA enhanced basal ERK1/2 phosphorylation and promoted cell proliferation. Apart from its role in growth arrest, impairment of ERK1/2 also contributed to the resistance of senescent cells to oxidant-elicited cell injury. These results therefore indicate that p53-mediated up-regulation of MKP-3 contributes to the establishment of the senescent cellular phenotype through dephosphorylating ERK1/2. Impairment of ERK1/2 activation could be an important mechanism by which p53 controls cellular senescence. © 2015 by The American Society for Biochemistry and Molecular Biology, Inc.


相关化合物

  • 2-(2-亚氨基-4,5,6,...

相关文献:

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.

1999-09-10

[Science 285 , 1733-1737, (1999)]

Suppression of p53: a new approach to overcome side effects of antitumor therapy.

2000-01-01

[Biochemistry 65 , 41-48, (2000)]

更多文献...